Active Biotech AB publ
STO:ACTI
Active Biotech AB publ?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.069
0.36
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Active Biotech AB publ hold over its rivals?
What risks and challenges
does Active Biotech AB publ face in the near future?
Provide an overview of the primary business activities
of Active Biotech AB publ.
Show me price targets
for Active Biotech AB publ made by professional analysts.
Provide an overview of the primary business activities
of Active Biotech AB publ.
What unique competitive advantages
does Active Biotech AB publ hold over its rivals?
What risks and challenges
does Active Biotech AB publ face in the near future?
Has there been any significant insider trading activity
in Active Biotech AB publ recently?
Show all valuation multiples
for Active Biotech AB publ.
Provide P/S
for Active Biotech AB publ.
Provide P/E
for Active Biotech AB publ.
Provide P/OCF
for Active Biotech AB publ.
Provide P/FCFE
for Active Biotech AB publ.
Provide P/B
for Active Biotech AB publ.
Provide EV/S
for Active Biotech AB publ.
Provide EV/GP
for Active Biotech AB publ.
Provide EV/EBITDA
for Active Biotech AB publ.
Provide EV/EBIT
for Active Biotech AB publ.
Provide EV/OCF
for Active Biotech AB publ.
Provide EV/FCFF
for Active Biotech AB publ.
Provide EV/IC
for Active Biotech AB publ.
Show me price targets
for Active Biotech AB publ made by professional analysts.
What are the Revenue projections
for Active Biotech AB publ?
How accurate were the past Revenue estimates
for Active Biotech AB publ?
What are the Net Income projections
for Active Biotech AB publ?
How accurate were the past Net Income estimates
for Active Biotech AB publ?
What are the EPS projections
for Active Biotech AB publ?
How accurate were the past EPS estimates
for Active Biotech AB publ?
What are the EBIT projections
for Active Biotech AB publ?
How accurate were the past EBIT estimates
for Active Biotech AB publ?
Compare the revenue forecasts
for Active Biotech AB publ with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Active Biotech AB publ and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Active Biotech AB publ against its competitors.
Analyze the profit margins
(gross, operating, and net) of Active Biotech AB publ compared to its peers.
Compare the P/E ratios
of Active Biotech AB publ against its peers.
Discuss the investment returns and shareholder value creation
comparing Active Biotech AB publ with its peers.
Analyze the financial leverage
of Active Biotech AB publ compared to its main competitors.
Show all profitability ratios
for Active Biotech AB publ.
Provide ROE
for Active Biotech AB publ.
Provide ROA
for Active Biotech AB publ.
Provide ROIC
for Active Biotech AB publ.
Provide ROCE
for Active Biotech AB publ.
Provide Gross Margin
for Active Biotech AB publ.
Provide Operating Margin
for Active Biotech AB publ.
Provide Net Margin
for Active Biotech AB publ.
Provide FCF Margin
for Active Biotech AB publ.
Show all solvency ratios
for Active Biotech AB publ.
Provide D/E Ratio
for Active Biotech AB publ.
Provide D/A Ratio
for Active Biotech AB publ.
Provide Interest Coverage Ratio
for Active Biotech AB publ.
Provide Altman Z-Score Ratio
for Active Biotech AB publ.
Provide Quick Ratio
for Active Biotech AB publ.
Provide Current Ratio
for Active Biotech AB publ.
Provide Cash Ratio
for Active Biotech AB publ.
What is the historical Revenue growth
over the last 5 years for Active Biotech AB publ?
What is the historical Net Income growth
over the last 5 years for Active Biotech AB publ?
What is the current Free Cash Flow
of Active Biotech AB publ?
Discuss the annual earnings per share (EPS)
trend over the past five years for Active Biotech AB publ.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
SE |
A
|
Active Biotech AB publ
STO:ACTI
|
230m SEK | -5.1 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -194 560.6 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
334.3B USD | 15.3 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
160.4B USD | 14.5 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
139.1B USD | 10.1 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.1B USD | 25.4 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -580.7 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
117.5B AUD | 17.3 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
59.2B USD | 11.8 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -66.6 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
43.3B USD | -720.3 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
SE |
A
|
Active Biotech AB publ
STO:ACTI
|
Average EV/EBITDA:
15.7
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -194 560.6 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
15.3
|
13%
|
1.2 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
14.5
|
17%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
10.1
|
6%
|
1.7 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
25.4
|
17%
|
1.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -580.7 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
17.3
|
11%
|
1.6 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
11.8
|
11%
|
1.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -66.6 | N/A | N/A |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -720.3 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.